Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Net sales $ 5,886,000 $ 3,207,643
Cost of products sold 3,451,646 1,719,737
Gross profit 2,434,354 1,487,906
Operating expenses:    
Selling, general and administrative 682,321 299,425
Salaries and wages 2,253,810 928,170
Professional fees 244,739 59,026
Depreciation 80,092 46,523
Research and design 221,545
Total operating expenses 3,482,507 1,333,144
(Loss) income from operations (1,048,153) 154,762
Other (expense) income:    
Other income 598
Interest expense (39,840) (17,712)
Interest income 24
Loss on disposal of assets (18,408) (5,101)
Net change in fair value of marketable securities (85,538)
Total other expenses (143,164) (22,813)
Net (loss) income $ (1,191,317) $ 131,949
Basic and dilutive (loss) income per share of common stock $ (0.17) $ 0.03
Weighted average number of shares of common stock outstanding 7,000,000 4,000,000